FREE TRIAL - NO CARD NEEDED
Pubrio gives your team the data, timing, and tools to reach the right prospects before the competition does.
Company & people search
Filter 560M+ contacts by role, industry, tech stack & more.
Sequences
Automate multi-step outreach without losing the personal touch.
Market signals
Stay ahead of every market shift. Pubrio Signals watches companies for you and delivers the right intelligence.
Start your free trial
Join 9,000+ revenue teams already using Pubrio.
No credit card · Cancel anytime · GDPR safe
Already have an account?Log in
Switzerland · Pharmaceutical Manufacturing
Pharmaceuticals
Biotechnology
Health Care
Pharmaceutical Manufacturing
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university or biotech start-up has interesting molecules in early-stage research and you’re seeking a competent and committed partner to develop them further, please contact us!
1979
Founded
Pharmaceutical Manufacturing
Industry
Switzerland
Location
252,946
Ranking
500 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© Pubrio 2026
